ES8606494A1 - Un metodo de producir un peptido o polipeptido sintetico. - Google Patents

Un metodo de producir un peptido o polipeptido sintetico.

Info

Publication number
ES8606494A1
ES8606494A1 ES529232A ES529232A ES8606494A1 ES 8606494 A1 ES8606494 A1 ES 8606494A1 ES 529232 A ES529232 A ES 529232A ES 529232 A ES529232 A ES 529232A ES 8606494 A1 ES8606494 A1 ES 8606494A1
Authority
ES
Spain
Prior art keywords
falciparum
dna molecules
plasmodium falciparum
expression
antigenicity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES529232A
Other languages
English (en)
Other versions
ES529232A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Walter and Eliza Hall Institute of Medical Research
Original Assignee
Walter and Eliza Hall Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter and Eliza Hall Institute of Medical Research filed Critical Walter and Eliza Hall Institute of Medical Research
Publication of ES8606494A1 publication Critical patent/ES8606494A1/es
Publication of ES529232A0 publication Critical patent/ES529232A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

METODO DE PRODUCIR UN PEPTIDO O POLIPEPTIDO SINTETICO. COMPRENDE: A) CULTIVAR UNA CELULA HUESPED QUE CONTIENE: I) UNA MOLECULA DE ADN RECOMBINANTE QUE COMPRENDE UNA SECUENCIA DE NUCLEOTIDOS CAPAZ DE SER EXPRESADA COMO UN POLIPEPTIDO QUE MUESTRA LA ANTIGENICIDAD DE UN ANTIGENO DE P. FALCIPARUM (LIMITADA OPERATIVAMENTE A UNA SECUENCIA DE CONTROL DE EXPRESION); O II) UN VEHICULO O VECTOR DE CLONACION DE ADN RECOMBINANTE QUE TIENE INSERTADA EN EL UNA SECUENCIA DE NUCLEOTIDOS CAPAZ DE SER EXPRESADA COMO UN POLIPEPTIDO QUE MUESTRA LA ANTIGENICIDAD DE UN ANTIGENO DE P. FALCIPARUM (ESTANDO DICHA SECUENCIA OPERATIVAMENTE UNIDA A UNA SECUENCIA DE CONTROL DE EXPRESION); Y B) RECUPERAR DICHO PEPTIDO O POLIPEPTIDO DEL CULTIVO. SE UTILIZA EN FARMACOLOGIA EN EL TRATAMIENTO Y LA PREVENCION DE LA MALARIA.
ES529232A 1983-01-28 1984-01-27 Un metodo de producir un peptido o polipeptido sintetico. Expired ES8606494A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPF784383 1983-01-28
AUPF978883 1983-06-10

Publications (2)

Publication Number Publication Date
ES8606494A1 true ES8606494A1 (es) 1986-04-16
ES529232A0 ES529232A0 (es) 1986-04-16

Family

ID=25642630

Family Applications (1)

Application Number Title Priority Date Filing Date
ES529232A Expired ES8606494A1 (es) 1983-01-28 1984-01-27 Un metodo de producir un peptido o polipeptido sintetico.

Country Status (15)

Country Link
EP (1) EP0134799B1 (es)
JP (1) JPH06225786A (es)
AU (1) AU569722B2 (es)
DE (1) DE3486110D1 (es)
DK (1) DK467484D0 (es)
ES (1) ES8606494A1 (es)
GB (1) GB2143830B (es)
GR (1) GR81750B (es)
IL (1) IL70776A (es)
MY (1) MY102594A (es)
NO (1) NO843872L (es)
OA (1) OA07823A (es)
PT (1) PT78032B (es)
SG (1) SG41089G (es)
WO (1) WO1984002917A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
EP0135108A3 (en) * 1983-08-12 1988-07-13 Rockefeller University Nucleotide hybridization assay for protozoan parasites
AU584881B2 (en) * 1984-02-21 1989-06-08 British Technology Group Limited Improvements in or relating to the production of malaria vaccines
IL74409A (en) * 1984-02-22 1994-08-26 Wellcome Found Cloning of the p195 gene of p. falciparum and fragments thereof
US5126264A (en) * 1984-09-11 1992-06-30 The Walter & Eliza Hall Institute Of Medical Research The RESA and FIRA antigens of plasmodium falciparum
IL76338A (en) * 1984-09-11 1994-08-26 Saramane Pty Ltd Plasmodium plasmodium immunogenic polypeptides, AND molecules encoding them, a method for preparing the polypeptides and preparations containing the polypeptide
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
AU5293486A (en) * 1985-02-07 1986-08-14 Smithkline Beckman Corporation Malaria vaccine against plasmodium falciparum
WO1986004922A1 (en) * 1985-02-20 1986-08-28 Memorial Sloan-Kettering Cancer Center cDNA CODING FOR PLASMODIUM FALCIPARUM GLYCOPHORIN BINDING PROTEINS WEIGHING 130,000 DALTONS AND 155,000 DALTONS
ZW8386A1 (en) * 1985-04-11 1986-07-23 Inst Medical W & E Hall Highly repetitive antigens of plasmodium falciparum
IL79880A0 (en) * 1985-08-29 1986-11-30 Inst Medical W & E Hall Recombinant virus
IL81026A0 (en) * 1985-12-24 1987-03-31 Inst Medical W & E Hall Peptides for immunizing against plasmodium falciparum,dna molecules coding for them and compositions containing said peptides
IL81890A0 (en) * 1986-03-14 1987-10-20 Saramane Pty Ltd Polypeptides providing protective immunity against malaria
US5006514A (en) * 1986-03-20 1991-04-09 Sawai Pharmaceutical Co., Ltd. α,α-trehalose trimycolates and pharmaceutical compositions
FR2610631B1 (fr) * 1987-02-09 1989-11-24 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum dans les hepatocytes, et leurs utilisations, notamment pour le diagnostic du paludisme ou dans des compositions de vaccins contre le paludisme
FR2672290B1 (fr) 1991-02-05 1995-04-21 Pasteur Institut Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t.
DE3741057A1 (de) * 1987-03-18 1988-09-29 Behringwerke Ag Klonierung von malaria-spezifischen dna-sequenzen:isolierung des gens fuer das 140 kd protein
ZA888983B (en) * 1987-12-01 1989-08-30 Saramane Pty Ltd Rhoptry antigen of plasmodium falciparum
GB2228936A (en) * 1988-02-12 1990-09-12 Saramane Pty Ltd Rhoptry membrane antigen of plasmodium falciparum
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
GB8905857D0 (en) * 1989-03-14 1989-04-26 Hoffmann La Roche Plasmodium merozoite rhoptries antigen
CA2011031C (en) * 1989-03-14 2000-07-18 Robert George Ridley Plasmodium merozoite rhoptries antigen and derivatives thereof
GB9002512D0 (en) * 1990-02-05 1990-04-04 3I Res Expl Ltd Polypeptides and dna encoding same
KR20020028385A (ko) * 2000-10-09 2002-04-17 박제철 마커를 이용한 말라리아 원충에 감염된 모기 검출방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5434837B2 (es) * 1972-02-08 1979-10-29
DE3033776A1 (de) * 1980-09-09 1982-04-22 Behringwerke Ag, 3550 Marburg Verfahren zur vermehrung von protozoen
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
JPS57156421A (en) * 1981-03-24 1982-09-27 Nippon Koutai Kenkyusho:Kk Malaria vaccine and its preparation
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
JPS5810524A (ja) * 1981-04-15 1983-01-21 ザ・ウエルカム・フアウンデ−シヨン・リミテツド 保護誘発、蛋白性抗原
DE3280028D1 (en) * 1981-05-21 1989-12-28 Wellcome Found Protozoal antigen
GB2099300B (en) * 1981-05-21 1985-02-27 Wellcome Found Antigens from parasites of the genus plasmodium
WO1983002896A1 (en) * 1982-02-17 1983-09-01 D'antonio, Lawrence, E. Method for the purification of parasite antigenic factors
DE3221881A1 (de) * 1982-06-09 1983-12-15 Münchener Apparatebau Kimmel GmbH, 8012 Ottobrunn Verfahren zur herstellung eines impfstoffs gegen parasitaere krankheitserreger

Also Published As

Publication number Publication date
EP0134799A4 (en) 1985-07-30
IL70776A0 (en) 1984-04-30
AU569722B2 (en) 1988-02-18
SG41089G (en) 1989-12-22
OA07823A (en) 1986-11-20
PT78032A (en) 1984-02-01
AU2384284A (en) 1984-08-09
IL70776A (en) 1991-09-16
DE3486110D1 (de) 1993-04-29
DE3486110T2 (es) 1993-09-09
GB2143830A (en) 1985-02-20
GB2143830B (en) 1987-02-25
PT78032B (en) 1986-03-27
DK467484A (da) 1984-09-28
MY102594A (en) 1992-08-17
GR81750B (es) 1984-12-12
NO843872L (no) 1984-09-27
GB8424104D0 (en) 1984-10-31
EP0134799A1 (en) 1985-03-27
JPH06225786A (ja) 1994-08-16
EP0134799B1 (en) 1993-03-24
ES529232A0 (es) 1986-04-16
WO1984002917A1 (en) 1984-08-02
DK467484D0 (da) 1984-09-28

Similar Documents

Publication Publication Date Title
ES8606494A1 (es) Un metodo de producir un peptido o polipeptido sintetico.
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
WO2000075350A3 (en) Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
ZA953629B (en) Soluble polypeptidic fragments of lag-3 protein method of production thereof therapeutic composition anti-idiotype antibodies
AU2964489A (en) Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
ES2009238A6 (es) Metodo para producir proteinas de mycobacterium tuberculosis y peptidos antigenicos de las mismas.
EP0997477A3 (en) MHC complexes and uses thereof
EP0305488A4 (en) Mycobacterial recombinants and peptides
AU7565991A (en) Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
IL69469A (en) Polypeptide having human h1-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
OA09116A (en) Novel protein, sequences containing the gene therefore vectors, methods of preparation and use.
AU3802595A (en) Tripeptidyl aminopeptidase
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
WO2001025438A3 (en) Ifn-alpha homologues
ZA839358B (en) The cloning and expression of nucleotide sequences encoding bovine growth hormone
AU5112990A (en) Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum
OA09152A (en) Synthetic peptides related to HIV-ENV proteins.
MY102593A (en) Antigents of plasmodium falciparum
ES2006730A6 (es) Un metodo de preparar un peptido o polipeptido sintetico que presenta la antigenicidad de la totalidad o una parte de un antigeno de p. falciparum
PT85538A (en) Process for preparing homogeneous recombinant immune interferon fragments
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
NZ233672A (en) Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence
EP0146903A3 (en) Production of a vector encoding a novel hybrid interferon species

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010301